Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Forthright who wrote (424)	6/12/1998 5:48:00 PM
From: Hyrulean King	Read Replies (1) \| Respond to of 5402

ok

To: Mr. Forthright who wrote (424)	6/12/1998 5:54:00 PM
From: Profiteer	Read Replies (1) \| Respond to of 5402

Quote the Chief:<<This is the actually the beginning of a something thats been going on since 1968.>> Mr. Forthright:<<Things don't happen overnight in biotech!>> MAN! How old are you... 110????

To: Mr. Forthright who wrote (424)	6/12/1998 5:57:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

I love a good STORY.. The other day there was a small group of Indians watchin somebody ,, the next thing ya knew they had him burried in an Ant-bed up to his neck... I could hear him screamin fer days.. over the hill there about where yer a standin... Oh it must of been a terrible sight with those ants crawlin up his nose and in his ears.. terrible it was screamin all night long.... Prospector ( I love a good story )

To: Mr. Forthright who wrote (424)	6/12/1998 6:22:00 PM
From: drdan	Read Replies (3) \| Respond to of 5402

Mr Forthright , you seem to be commenting about Sanguine by lumping it in with another company as you just did. Look, there is no hard data to support the claims of this product. There is unpublished evidence from a trial of 15000 Japanese in a 15-year span leading up to approval f Fluosol in JAPAN IN 1989. IT WAS banned in Japan due to someone using it illegally on a patient before it was offcially pproved inJapan. It had nothing to do with the performance of the drug. The pher02 molecule is IDENTICAL to the fluosol molecule. The only differene is that the lipid emulsfer has fluorine bound to i so that the pher02 molecule is more tightly bound to the lipid. It seems to me that if the active ingredient of this new drug is IDENTICAL to the previously approved drug, dont you think that this drug as a good chance of being approved? Think about it.... there are so many drugs that are closely related structurally so that once one drug is approved, many similar ones are as well, in due time. Examples would be the beta blockers , the H-1 blockers(eg:zantac. tagamet,etc) and on and on. I could write about this until I am blue in the face, and you probably will remain unconvinced. OK. But please do not come here and compare apples and oranges with the example you gave. You are misleading people with no facts about this company or its product. At least I have anecdotal evidence and some evidence from the FDA. Show a bit more respect and perhaps others will do the same for you....